Vasoactive Intestinal Peptide
"Vasoactive Intestinal Peptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).
| Descriptor ID |
D014660
|
| MeSH Number(s) |
D06.472.317.950 D06.472.699.952 D12.644.400.875 D12.644.548.952 D12.776.631.650.875
|
| Concept/Terms |
Vasoactive Intestinal Peptide- Vasoactive Intestinal Peptide
- Intestinal Peptide, Vasoactive
- Peptide, Vasoactive Intestinal
- Vasoactive Intestinal Polypeptide
- Intestinal Polypeptide, Vasoactive
- Polypeptide, Vasoactive Intestinal
- VIP (Vasoactive Intestinal Peptide)
- Vasointestinal Peptide
- Peptide, Vasointestinal
|
Below are MeSH descriptors whose meaning is more general than "Vasoactive Intestinal Peptide".
Below are MeSH descriptors whose meaning is more specific than "Vasoactive Intestinal Peptide".
This graph shows the total number of publications written about "Vasoactive Intestinal Peptide" by people in this website by year, and whether "Vasoactive Intestinal Peptide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasoactive Intestinal Peptide" by people in Profiles.
-
Cell-type-specific plasticity of inhibitory interneurons in the rehabilitation of auditory cortex after peripheral damage. Nat Commun. 2023 Jul 13; 14(1):4170.
-
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future. Pharmacol Ther. 2016 08; 164:195-203.
-
Inhibitory stabilization and visual coding in cortical circuits with multiple interneuron subtypes. J Neurophysiol. 2016 Mar; 115(3):1399-409.
-
Clinical problem-solving. Needle in a haystack. N Engl J Med. 2009 Feb 05; 360(6):616-21.
-
Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther. 2009 Jan; 121(1):69-88.
-
Catalytic hydrolysis of VIP in pregnant women with asthma. J Asthma. 2006 Aug; 43(6):429-32.
-
Rat group I metabotropic glutamate receptors inhibit neuronal Ca2+ channels via multiple signal transduction pathways in HEK 293 cells. J Neurophysiol. 1998 Jan; 79(1):379-91.
-
Sterically stabilized phospholipids attenuate human neutrophils chemotaxis in vitro. Life Sci. 1998; 63(8):693-9.
-
Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ. Am J Physiol. 1996 Aug; 271(2 Pt 2):R393-7.
-
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry. 1996 Jan 15; 39(2):82-91.